A Randomized, Double-Blind, Placebo-Controlled Trial of CVN424 in Early Parkinson's Disease
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
Cerevance Beta, Inc.
Start Date
November 27, 2023
End Date
December 31, 2025
Administered By
Neurology, Movement Disorders
Awarded By
Cerevance Beta, Inc.
Start Date
November 27, 2023
End Date
December 31, 2025